2-(2-(Benzyloxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

n-Hexane, min 99 %, pour la synthèse, 10 l, PE/acier

6-Benzyl-2,4-dichloro-8,8-difluoro-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine, 95%, 1g

3-Chloro-2,6-dimethoxypyridin-4-ylboronic acid, 98%, 1g

2-Chloro-N-(6-ethoxybenzothiazol-2-yl)propanamide, 95%, 10g

2-(Trifluoromethyl)pyrimidine-5-carbaldehyde, 95.0%, 250mg

(2E)-1-(3,4-dichlorophenyl)-3-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 2g

Ethanesulfinic acid, sodium salt, 85.0%, 25g

1,1-Dimethyl-3-phenylurea, 95.0%, 5g

Récipient de réaction à bride plate cylindrique, gradué (1) Fond rond, DN 100, 160 mm, Hauteur, 360 mm, 1 Pièce

3-(4-(2-Methoxyethyl)phenoxy)propane-1,2-diol, 97%, 250mg

1,4-Diazaspiro[5.5]undecan-3-one, 97%, 5g

2,3-Dichloro-6-methyl-5-nitropyridine, 98%, 100mg